Clostridium difficile, a major cause of healthcare-associated infections (HAI), is classified as an “urgent threat” in the CDC’s latest report on Antibiotic Resistance Threats¹.
Clostridium difficile, a major cause of healthcare-associated infections (HAI), is classified as an “urgent threat” in the CDC’s latest report on Antibiotic Resistance Threats¹. Its increasing prevalence and high levels of morbidity and mortality are serious concerns on both human health and economic fronts. C. difficile infection management involves a full-circle range of measures covering prevention, diagnosis, therapies, surveillance, outbreak management and epidemiology. With its global solution, bioMérieux is your partner in fighting C. difficile.